Union Bancaire Privee’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.5M Buy
108,638
+2,076
+2% +$243K 0.26% 58
2026
Q1
$18.8M Sell
106,562
-179,007
-63% -$20.7M 0.26% 64
2025
Q4
$35.5M Sell
285,569
-105,312
-27% -$9.89M 0.42% 48
2025
Q3
$34.9M Buy
390,881
+23,780
+6% +$1.96M 0.5% 46
2025
Q2
$30.5M Buy
367,101
+280,275
+323% +$22.3M 0.44% 47
2025
Q1
$7.18M Sell
86,826
-192,512
-69% -$18M 0.14% 74
2024
Q4
$26.3M Buy
+279,338
New +$28.8M 0.46% 44

Other funds holding MRK

Union Bancaire Privee's MRK Position: Q2 2026 in Review

Union Bancaire Privee increased its Merck (MRK) stake by 1.9% in Q2 2026, buying an estimated $243K and bringing the position to 108,638 shares worth $23.5M. The position accounts for 0.26% of the portfolio, ranked #58.

Union Bancaire Privee first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $35.5M in Q4 2025. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Union Bancaire Privee held 108,638 shares of Merck worth $23.5M as of Q2 2026.
  • Union Bancaire Privee bought 2,076 Merck shares in Q2 2026, an estimated $243K.
  • Merck made up 0.26% of Union Bancaire Privee's portfolio in Q2 2026, its #58 holding.
  • Union Bancaire Privee first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Union Bancaire Privee's Merck position peaked at $35.5M in Q4 2025.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.